Cover Image
市場調查報告書

Protein Sciences Corporation的產品平台分析

Protein Sciences Corporation - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 259367
出版日期 內容資訊 英文 30 Pages
訂單完成後即時交付
價格
Back to Top
Protein Sciences Corporation的產品平台分析 Protein Sciences Corporation - Product Pipeline Review - 2015
出版日期: 2015年12月23日 內容資訊: 英文 30 Pages
簡介

Protein Sciences Corporation是總公司設立於美國的生物科技企業,從事疫苗及蛋白質產品的製造開發。銷售著治療流感,人類乳突病毒,生物武器國防,前列腺癌及乳癌,糖尿病,肌肉營養不良症,遺傳性脂質障礙,中樞神經障礙的疫苗,還有人類及動物疾病研究用基因改造蛋白質等產品。

本報告提供Protein Sciences Corporation 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Protein Sciences Corporation 基本資料

  • Protein Sciences Corporation 概要
  • 主要資訊
  • 企業資料

Protein Sciences Corporation :R&D概要

  • 主要的治療範圍

Protein Sciences Corporation :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Protein Sciences Corporation :開發中產品概況

  • 後期階段產品開發中產品
    • 申請前階段的產品/聯合治療模式
    • 第三階段的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Protein Sciences Corporation :藥物簡介

  • seasonal influenza (trivalent) vaccine
  • RIV-4
  • UMN-0501
  • D-3252

Protein Sciences Corporation :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型

Protein Sciences Corporation :最新的開發平台資訊

Protein Sciences Corporation :開發暫停中的計劃

Protein Sciences Corporation :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07915CDB

Summary

Global Markets Direct's, 'Protein Sciences Corporation - Product Pipeline Review - 2015', provides an overview of the Protein Sciences Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Protein Sciences Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Protein Sciences Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Protein Sciences Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Protein Sciences Corporation's pipeline products

Reasons to buy

  • Evaluate Protein Sciences Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Protein Sciences Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Protein Sciences Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Protein Sciences Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Protein Sciences Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Protein Sciences Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Protein Sciences Corporation Snapshot
    • Protein Sciences Corporation Overview
    • Key Information
    • Key Facts
  • Protein Sciences Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • Protein Sciences Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Protein Sciences Corporation - Pipeline Products Glance
    • Protein Sciences Corporation - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Protein Sciences Corporation - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Protein Sciences Corporation - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Protein Sciences Corporation - Drug Profiles
    • influenza [strains A/H1N1 + A/H3N2 + B] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RIV-4
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FluNhance
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PanBlok
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • D-3252
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Protein Sciences Corporation - Pipeline Analysis
    • Protein Sciences Corporation - Pipeline Products by Target
    • Protein Sciences Corporation - Pipeline Products by Route of Administration
    • Protein Sciences Corporation - Pipeline Products by Molecule Type
  • Protein Sciences Corporation - Recent Pipeline Updates
  • Protein Sciences Corporation - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Protein Sciences Corporation, Key Information
  • Protein Sciences Corporation, Key Facts
  • Protein Sciences Corporation - Pipeline by Indication, 2015
  • Protein Sciences Corporation - Pipeline by Stage of Development, 2015
  • Protein Sciences Corporation - Monotherapy Products in Pipeline, 2015
  • Protein Sciences Corporation - Combination Treatment Modalities in Pipeline, 2015
  • Protein Sciences Corporation - Pre-Registration, 2015
  • Protein Sciences Corporation - Phase III, 2015
  • Protein Sciences Corporation - Phase II, 2015
  • Protein Sciences Corporation - Preclinical, 2015
  • Protein Sciences Corporation - Pipeline by Target, 2015
  • Protein Sciences Corporation - Pipeline by Route of Administration, 2015
  • Protein Sciences Corporation - Pipeline by Molecule Type, 2015
  • Protein Sciences Corporation - Recent Pipeline Updates, 2015

List of Figures

  • Protein Sciences Corporation - Pipeline by Top 10 Indication, 2015
  • Protein Sciences Corporation - Pipeline by Stage of Development, 2015
  • Protein Sciences Corporation - Monotherapy Products in Pipeline, 2015
  • Protein Sciences Corporation - Combination Treatment Modalities in Pipeline, 2015
  • Protein Sciences Corporation - Pipeline by Top 10 Target, 2015
  • Protein Sciences Corporation - Pipeline by Top 10 Route of Administration, 2015
  • Protein Sciences Corporation - Pipeline by Top 10 Molecule Type, 2015
Back to Top